Nepafenac for epiretinal membrane

Ophthalmology

Volumn 118, Issue 7, 2011, Pages 1482.e1-1482.e3

  Schoenberger, Scott D ^a   Miller, Daniel M ^a   Petersen, Michael R ^a   Foster, Robert E ^a   Riemann, Christopher D ^a   Sisk, Robert A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEPAFENAC;

EPIRETINAL MEMBRANE; EYE SURGERY; HUMAN; IDIOPATHIC DISEASE; LETTER; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA MACULA EDEMA; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 79959946437     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2011.01.034     Document Type: Letter

References (5)

1. Falkner-Radler CI, Glittenberg C, Hagen S, et al. Spectraldomain optical coherence tomography for monitoring epiretinal membrane surgery. Ophthalmology 2010;117:798805.
2. Miyake K, Ibaraki N. Prostaglandins and cystoid macular edema. Surv Ophthalmol 2002;47:S20318.
3. Wittpenn JR, Silverstein S, Heier J, et al; Acular LS for Cystoid macular edema (ACME) study group. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs. steroid alone in low-risk cataract surgery patients. Am J Ophthalmol 2008;146:55460.
4. Kim SJ, Lo WR, Hubbard GB 3rd, et al. Topical ketorolac in vitreoretinal surgery: a prospective, randomized, placebocontrolled, double-masked trial. Arch Ophthalmol 2008;126: 12038.
5. Massin P, Allouch C, Haouchine B, et al. Optical coherence tomography of idiopathic macular epiretinal membranes before and after surgery. Am J Ophthalmol 2000;130:7329.